Conferences - Results from #9580

GU Cancers Symposium 2014 - Is surveillance the standard treatment for clinical stage I germ cell tumor? - Session Highlights February 3, 2014

GU Cancers Symposium 2014 - A decade in review: Building blocks in the progress in management of urothelial carcinomas - Session Highlights February 3, 2014

GU Cancers Symposium 2014 - A decade in review: Penile, urethral, and testicular cancers - Session Highlights February 3, 2014

GU Cancers Symposium 2014 - Patterns of relapse in poor-prognosis germ cell tumors in the GETUG 13 trial: Implications for assessment of brain progression - Session Highlights February 3, 2014

GU Cancers Symposium 2014 - Multicenter sequential phase II study of flavopiridol plus oxaliplatin (alvocidib) with or without 5-FU and leucovorin for patients with refractory germ cell tumors including late relapse - Session Highlights February 3, 2014

GU Cancers Symposium 2014 - Premature termination of genitourinary cancer clinical trials - Session Highlights February 3, 2014

GU Cancers Symposium 2014 - The initial report of RTOG 0524: Phase I/II trial of a combination of paclitaxel and trastuzumab with daily irradiation or paclitaxel alone with daily irradiation following transurethral surgery... February 3, 2014

GU Cancers Symposium 2014 - Evaluation of outcomes following centralization of cystectomy services in the United Kingdom - Session Highlights February 3, 2014

GU Cancers Symposium 2014 - Biology of bladder cancer metastases - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer analysis - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - The Cancer Genome Atlas (TCGA) bladder cancer update - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Next generation sequencing technologies: Advancing therapy for urothelial carcinoma - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Preclinical models for bladder cancer - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Keynote Lecture: Evolution of prostate cancer genomes - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Multimodal management of urothelial carcinoma - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - A pooled analysis of RTOG 9906 and 0233 - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Update on European Organisation for Research and Treatment of Cancer (EORTC) guidelines for bladder cancer - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Practical use of molecular markers in the management of bladder cancer - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Best of journals - urologic oncology - Session Highlights February 1, 2014

GU Cancers Symposium 2014 - Best of journals - radiation oncology - Session Highlights January 31, 2014

Page 480 of 524